4//SEC Filing
Exter Neil 4
Accession 0001567619-21-012593
CIK 0001628171other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 5:18 PM ET
Size
9.7 KB
Accession
0001567619-21-012593
Insider Transaction Report
Form 4
Exter Neil
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-22+12,659→ 12,659 totalExercise: $32.93Exp: 2031-06-21→ Common Stock (12,659 underlying) - Award
Common Stock
2021-06-22+3,617→ 23,615 total
Holdings
- 0(indirect: See footnotes)
Common Stock
- 19,998(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]The Reporting Person is a partner of each of Third Rock Ventures GP II, L.P., Third Rock Ventures GP III, L.P. and Third Rock Ventures GP IV, L.P. which is the general partner of each of Third Rock Ventures II, L.P. ("TRV II), Third Rock Ventures III, L.P. ("TRV III") and Third Rock Ventures IV, L.P. ("TRV IV" and collectively with TRV II and TRV III, "the Funds"), respectively. The Reporting Person disclaims beneficial ownership over the shares held by the Funds, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- [F2]TRV III directly holds 5,524,031 shares of Common Stock of the Issuer and TRV IV directly holds 1,419,900 shares of Common Stock of the Issuer.
- [F3]The shares are directly held in certain estate-planning trusts over which the Reporting Person may have voting and dispositive power. The Reporting Person disclaims beneficial ownership over the shares held by such trusts except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- [F4]Includes 3,617 Restricted Stock Units.
- [F5]Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 22, 2021 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001620014
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 5:18 PM ET
- Size
- 9.7 KB